Real-world EGFR testing in patients with stage IIIB/IV non-small-cell lung cancer in North China: A multicenter, non-interventional study-Reference-Cited by-全球学者库

Real-world EGFR testing in patients with stage IIIB/IV non-small-cell lung cancer in North China: A multicenter, non-interventional study

Published:2018-09-25 Issue:11 Volume:9 Page:1461-1469
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Cheng Ying¹,Wang Yan²,Zhao Jun³,Liu Yunpeng⁴,Gao Hongjun⁵,Ma Kewei⁶,Zhang Shucai⁷,Xin Hua⁸,Liu Jiwei⁹,Han Chengbo¹⁰,Zhu Zhitu¹¹,Wang Yan¹²,Chen Jun¹³,Wen Fugang¹⁴,Li Junling¹²,Zhang Jie¹⁵,Zheng Zhendong¹⁶,Dai Zhaoxia¹³,Piao Hongmei¹⁷,Li Xiaoling¹⁸,Li Yinyin¹⁹,Zhong Min²⁰,Ma Rui²¹,Zhuang Yongzhi²²,Xu Yuqing²³,Qu Zhuohui²⁴,Yang Haibo²⁵,Pan Chunxia²⁶,Yang Fan²⁷,Zhang Daxin²⁸,Li Bing²⁹

Affiliation:

1. Department of Medical Oncology; Jilin Provincial Cancer Hospital; Changchun China

2. Department of Internal Medical Oncology; Harbin Medical University Cancer Hospital; Harbin China

3. Department of Thoracic Oncology; Beijing Cancer Hospital; Beijing China

4. Department of Medical Oncology; The First Hospital of China Medical University; Shenyang China

5. Department of Lung Cancer; Affiliated Hospital of Academy of Military Medical Sciences; Beijing China

6. Department of Respiratory Medicine; The First Hospital of Jilin University; Changchun China

7. Department of Oncology; Beijing Chest Hospital; Beijing China

8. Department of Thoracic Surgery; China-Japan Union Hospital of Jilin University; Changchun China

9. Department of Oncology; The First Affiliated Hospital of Dalian Medical University; Dalian China

10. Department of Oncology; Shengjing Hospital of China Medical University; Shenyang China

11. Department of Cancer Center; The First Affiliated Hospital of Liaoning Medical University; Jinzhou China

12. Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital; Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing; China

13. Department of Medical Oncology; The Second Hospital of Dalian Medical University; Dalian China

14. Department of Oncology; Anshan Cancer Hospital; Anshan China

15. Department of Respiratory and Critical Care Medicine; The Second of Hospital of Jilin University; Changchun China

16. Department of Oncology; The General Hospital of Shenyang Military; Shenyang China

17. Department of Respiratory Medicine; Yanbian University Hospital; Yanbian China

18. Department of Medical Oncology; Liaoning Cancer Hospital; Shenyang China

19. Department of Oncology; Shenyang Chest Hospital; Shenyang China

20. Department of Medical Oncology; Dalian Municipal Central Hospital; Dalian China

21. Department of Thoracic; Liaoning Cancer Hospital; Shenyang China

22. Department of Oncology; Daqing Oilfield General Hospital; Daqing China

23. Medical Department; The Second Affiliated Hospital of Harbin Medical University; Harbin China

24. Department of Oncology; Siping Cancer Hospital; Siping China

25. Department of Oncology; Jilin Municipal Cancer Hospital; Jilin China

26. Department of Medical Oncology; Third People's Hospital of Dalian; Dalian China

27. Department of Thoracic Surgery; Peking University People's Hospital; Beijing China

28. Department of Oncology; The First Affiliated Hospital of Harbin Medical University; Harbin China

29. Department of Medical Oncology; Jilin Center Hospital; Jilin China

Funder

Health and Family Planning Commission of Jilin Province

AstraZeneca

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1759-7714.12859/fullpdf

Reference27 articles.

1. Cancer statistics, 2018;Siegel;CA Cancer J Clin,2018

2. Cancer statistics in China, 2015;Chen;CA Cancer J Clin,2016

3. Cancer incidence and mortality in China, 2014;Chen;Chin J Cancer Res,2018

4. Non-small-cell lung cancer;Gridelli;Nat Rev Dis Primers,2015

5. Non-small cell lung cancer, Version 6.2015;Ettinger;J Natl Compr Cancer Netw,2015

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regional differences in epidermal growth factor receptor-tyrosine kinase inhibitor therapy in lung cancer treatment using a national database in Japan;Scientific Reports;2023-03-30

2. A combined preoperative red cell distribution width and carcinoembryonic antigen score contribute to prognosis prediction in stage I lung adenocarcinoma;World Journal of Surgical Oncology;2023-02-22

3. Non‐small cell lung cancer in China;Cancer Communications;2022-09-08

4. Efficacy and potential resistance mechanisms of afatinib in advanced non–small cell lung cancer patients with EGFR G719X / L861Q / S768I;Cancer;2022-09-07

5. Association between squamous cell carcinoma antigen level and EGFR mutation status in Chinese lung adenocarcinoma patients;Journal of Clinical Laboratory Analysis;2022-07-15